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Abstract: TMEM45A (DERP7, DNAPTP4 or FLJ10134) gene,
belonging to the TMEM family encoding predicted
transmembrane proteins, is highly expressed in epidermal
keratinocytes. To investigate the potential involvement of
TMEM45A during the differentiation and keratinization processes,
its expression has been characterized in normal human
keratinocytes and the protein subcellular localization has been
studied in this cell type, both in vitro and in vivo. TMEM45A
expression is upregulated with differentiation, either induced by
cultured keratinocyte confluence or enhanced Ca2+ concentration
in medium. In vivo, TMEM45A mRNA and protein are mostly
found in the granular layer of the epidermis. TMEM45A
expression is linked to keratinization, as accumulation of the
protein is detected in native and reconstructed epidermis as well
as in thymic Hassal bodies, but not in non-keratinized stratified
epithelia. At the subcellular level, co-detection with ER and Golgi
markers reveals that TM protein 45A is associated with the Golgi
apparatus and more specifically with the trans-Golgi/trans-Golgi
network in vitro and in granular layer in vivo. The protein is
neither related to lysosomes nor transported within
corneodesmosin-containing lamellar bodies. These data
demonstrate a strong correlation between TMEM45A expression
and epidermal keratinization, indicating the relevance of this gene
in this process.
Abbreviations: CALN, calnexin; CDSN, corneodesmosin; ER,
endoplasmic reticulum; FLG, filaggrin; IVL, involucrin; KLK7, kallikrein 7;
KRT, keratin; TM protein 45A, transmembrane protein 45A.
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Introduction
The epidermis is a squamous stratified epithelium where keratino-
cytes follow a unique programme of terminal differentiation and
cell death that leads to the formation of the cornified layer, the
outermost skin barrier. During this so-called keratinization pro-
cess, the cell content including all organelles is replaced by com-
pacted keratin filaments. At the cytoplasmic side of plasma
membrane, various proteins are enzymatically cross-linked to form
a cornified envelope. Finally, modifications of lipids secreted in
the intercellular spaces occur, leading to the formation of a hydro-
phobic matrix (1). Many keratinizing disorders in humans have
been identified resulting from mutations in genes critical for ker-
atinization (e.g. keratins, filaggrin, loricrin, SPINK5, transgluta-
minases), for anchoring junctions or for lipids metabolism (2–5).
Currently, our knowledge about gene expression during keratini-
zation remains incomplete (6). However, recent transcriptomic
studies allowed identification of yet unknown although potentially
major actors of this process. Indeed, a transcriptomic study based
on reconstructed human epidermis classified the still poorly char-
acterized TMEM45A gene in a cluster particularly highly expressed
at the late differentiation stage (7). This cluster also contains
numerous genes of the epidermal differentiation complex and gath-
ers genes implicated in ectoderm and epidermis development, mor-
phogenesis and keratinization. Moreover, according to BioGPS (8),
skin is the tissue expressing TMEM45A mRNA at the highest level.
TMEM45A gene (also called DERP7, DNAPTP4 or FLJ10134)
belongs to the large family of genes encoding uncharacterized pre-
dicted transmembrane (TMEM) proteins. To date, almost all
available information about TMEM45A is coming from transcrip-
tomic studies, databases or bioinformatics predictive tools. Seven
transcripts have been reported, but only three isoforms of trans-
membrane protein 45A (TM protein 45A) have been detected: first
contains 191 amino acids with 21.9 kDa MW, a second contains
275 amino acids with 31.7 kDa MW and a third contains 291
amino acids with 33.5 kDa MW, according to Ensembl (9). The
isoforms contain three, five or seven predicted transmembrane
domains, according to PredictProtein (10) and SOSUI (11), thus
they are suspected to be integral proteins according to Uniprot
(12). Subcellular localization and functions remain unknown.
Recently, we briefly reported selective induction of TMEM45A
expression in differentiating keratinocytes, as well as increased
expression in normal human epidermis (13), data later confirmed
by others (14). Finally, in an approach using keratinocytes frac-
tions purified from normal epidermis, TMEM45A was reported as
a differentiation-associated gene, because of its significantly higher
mRNA level in granular and cornified keratinocytes-enriched
fraction compared with its level in basal keratinocytes-enriched
fraction (15).
In addition, our current knowledge about TMEM45A is also
incomplete in pathological conditions. Regarding skin pathology,
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no significant variation in TMEM45A mRNA was observed
between healthy skin biopsies and atopic dermatitis, basal cell car-
cinoma, squamous cell carcinoma or melanoma biopsies, whereas
a significant upregulation was observed in psoriasis and actinic
keratosis (14,16). Moreover, TMEM45A with other genes involved
in differentiation (e.g. FLG, LOR, KRT10) was found downregu-
lated in cutaneous squamous cell carcinoma in comparison with
actinic keratosis (17). However, how alterations of TMEM45A
expression are involved in diseases remains to be solved. In cancer
cells, though, TMEM45A expression is implicated in resistance
against drug-induced apoptosis in hypoxic conditions by a still
unknown mechanism (13). Conversely, it suppresses the progres-
sion of ductal carcinoma into invasive breast cancer, again by an
unknown mechanism (18).
Here, we further characterized the expression of the new poten-
tial epidermal actor TMEM45A in vitro and in vivo to assess its
particular involvement in the keratinization process. Next, we
studied subcellular localization of the TM protein 45A in keratino-
cytes to get more insight into its potential functions.
Materials & methods
Antibodies, immunogenic peptide and chemicals
The list is available in the Supplementary Material.
Isolation of normal human keratinocytes and induction of
differentiation in autocrine cultures
Primary keratinocytes were isolated from normal human adult
abdominal skin collected at plastic surgery after written informed
consent of patients (Dr. B. Bienfait, Clinique St Luc, Namur, Bel-
gium). Cells were cultured in autocrine conditions as described
(19). All experiments were carried out according to the Declara-
tion of Helsinki Principles and were approved by the Medical Eth-
ical Committee of Clinique St Luc.
Calcium-induced differentiation of keratinocytes
Keratinocytes monolayers were seeded at very low cell density
(5000 cells/cm2) and then incubated with the usual medium con-
taining 0.06 mM Ca2+ (control) or with a medium supplemented
with Ca2+ (1.5 mM) for 48 h before extraction of total RNA.
Brefeldin A incubation
Confluent monolayers of keratinocytes were incubated with 10 lg/
ml brefeldin A for 30 min.
Reconstruction of human epidermis and processing for
histology
Reconstructed human epidermis were produced and analysed as
described (20), except fixation in 70% ethanol (100%), 10% for-
malin and 5% glacial acetic acid.
Human normal mouth epithelium, abdominal skin and
thymus sections
A lip fragment was obtained thanks to Pr. Pierre Garin and Alain
Koninckx (Laboratoire d’anatomie, University of Namur, Namur,
Belgium) from two individuals at autopsy. Abdominal skins were
collected from plastic surgery (Dr. B. Bienfait, Clinique St. Luc,
Namur, Belgium). A normal thymus fragment was obtained from
a young child undergoing corrective cardiovascular surgery for
congenital cardiomyopathy. Tissues were embedded in OCT com-
pound, and serial cryosections of 6–8 lm thick were obtained.
Immunofluorescence and immunoperoxidase labelling on
tissues and cells
Protocols are available in the Supplementary Material.
Real-time RT-PCR for keratinocyte monolayers and
reconstructed human epidermis
Total RNA of monolayers was isolated using High Pure RNA iso-
lation kit (Roche, Basel, Switzerland), according to manufacturer’s
instructions. Total RNA of reconstructed human epidermis was
isolated using RNeasy mini kit (Qiagen, Hilden, Germany), using
spin technology for animal cells according to manufacturer’s
instructions. 1 lg of total RNA was reverse transcribed using
SuperScript II kit (Life technologies, Carlsbad, California, USA),
according to the manufacturer’s instructions. Amplification reac-
tion assays contained FastStart Universal SYBR Green Master
(Rox) (Roche) and 300 nM of primers for real-time PCR. Primer
sequences are available in the Supplementary Material. The geo-
metric mean of RPLP0 and TBP house-keeping genes values was
used for normalization (21). mRNA expression level was quanti-
fied using the threshold cycle method on a 7300 real-time PCR
machine (Life technologies).
Epidermal dissociation
Four fractions (T1, T2, T3 and T4) were obtained from normal
human abdominal epidermis after successive dissociations of
keratinocytes by serial incubations in trypsin-EDTA, as described
in (6). Total RNA was extracted from fractions using the RNeasy
extraction kit (Qiagen). Three hundred ng of total RNA of each
fraction was reverse transcribed using a mixture of dNTPs and
random hexamer primers. Amplification assays were performed
with the ABI prism 7000 Sequence Detection System and analysed
with the corresponding software (Life technologies) using the
Maxima Probe/ROX qPCR master mix (Thermo Fisher Scientific,
Waltham, MA, USA). Fluorescence was quantified as threshold
cycle values. Primer sequences are available in the Supplementary
Material. mRNA levels were normalized to HPRT1 house-keeping
gene expression levels. This work was performed on skin from
two different donors.
Statistical analysis
Independent experiments were performed at least in triplicates
except for mRNA analysis of epidermal dissociation. Statistical sig-
nificance was evaluated by one-way repeated-measures analysis of
variance with a Holm–Sidak correction, except for analysis of cal-
cium-induced differentiation for which we used the paired t-test.
Data values were expressed as relative quantification level with
error bars representing 95% confidence intervals.
Results
TMEM45A is upregulated during keratinocyte
differentiation in vitro
In autocrine cultures of human epidermal keratinocytes, confluent
cells lose their clonogenicity (22) and initiate a limited differentia-
tion programme, as shown by the expression of early and late mark-
ers (19). Relative levels of TMEM45A mRNA were quantified at
different time points of culture, before and after confluence
(Fig. 1a). A very highly significant increase in TMEM45A expres-
sion was observed after confluence with an expression profile simi-
lar to the differentiation markers keratin-10 (KRT10) and
involucrin (IVL). The TM protein 45A expression was then analy-
sed with an affinity-purified peptide antibody as already described
(13). The specificity of this antibody was first further validated
using competition with the immunogenic peptide (Figure S1).
Then, the transmembrane protein 45A was labelled in autocrine
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cultures of keratinocytes at subconfluence, confluence and postcon-
fluence (Fig. 1b). Our data illustrate that immunoreactivity is
found at each stage and increases at culture confluence and later.
Concomitant detections of the TM protein 45A and both of KRT10
and IVL in differentiating keratinocytes were also established using
immunofluorescence co-labelling after culture confluence (Fig. 1c).
To analyse whether TMEM45A gene expression is related to differ-
entiation rather than to the high cell density obtained at confluence,
its mRNA levels were measured after induction of differentiation by
an increased Ca2+ concentration in culture medium. Keratinocytes
at low cell density were cultured with a high (1.5 mM) or low
(0.06 mM) calcium concentration for 48 h. A very highly significant
increase in KRT10 and IVL expression confirmed the commitment
towards differentiation induced by high calcium concentration in
the medium (Figure S2). Simultaneously, TMEM45A expression
was also significantly increased, further demonstrating its link with
epidermal differentiation.
TMEM45A is predominantly expressed by the most
differentiated living keratinocytes of the epidermis and is
related to keratinization
TM protein 45A immunoreactivity (Fig. 1d, e) was found in all
epidermal layers, in fibroblasts and skin appendages (data not
shown) in normal human abdominal skin; however, the strongest
signal in epidermis was observed in the granular layer. Weaker sig-
nals were noticed in basal and spinous layers. To overcome the
limited resolution of chromogenic immunohistochemistry, obser-
vations using confocal microscopy were performed after immuno-
fluorescence labelling (Fig. 1f, g). In granular layer, a punctated
cytoplasmic signal was observed, whereas a rather lamellar signal
was localized in the lower part of the cornified layer. Furthermore,
TMEM45A relative mRNA levels were quantified in the four frac-
tions of enriched keratinocytes (T1, T2, T3 and T4) obtained after
serial incubations of epidermal fragments with trypsin solution
(6). T1 fraction was enriched in undifferentiated keratinocytes and
T4 fraction in keratinocytes from granular and cornified layers; T2
and T3 contained keratinocytes with an intermediate phenotype.
This experiment was performed twice with epidermis from differ-
ent donors (one representative experiment is shown in Fig. 1h).
KRT14 as a marker of basal keratinocytes together with kallikrein
7 (KLK7) and corneodesmosin (CDSN) as markers of granular
cells were used as internal controls to assess successful enrichment.
The highest relative TMEM45A mRNA level was observed in T4,
confirming that TMEM45A expression is predominant in differen-
tiating keratinocytes.
A model of epidermal reconstruction in vitro was then used to
follow TMEM45A expression during morphogenesis and keratini-
zation in culture (20). No statistically significant variation in
TMEM45A relative mRNA level was observed during morphogen-
esis (Figure S3a), indicating that TMEM45A transcript abundance
increases concomitantly with the amount of transcripts encoded
by house-keeping genes during tissue reconstruction. The immu-
noreactivity for transmembrane protein 45A (Figure S3b) was
detected in suprabasal (spinous and granular) layers, from 3 days
of reconstruction on, when corneocytes appear at the air–liquid
interface.
To determine whether TM protein 45A accumulation in strati-
fied epithelia relates to keratinization, immunohistochemical
detection of the protein was performed on samples of human nor-
mal mouth epithelia from two different donors. In parallel to the
absence of keratinization in this epithelium, no TM protein 45A
immunoreactivity was found in suprabasal layers, conversely to
the epidermis (Fig. 2a–d). These data indicate that, in non-kerati-
nized keratinocytes, TMEM45A expression is not enhanced like in
the epidermis. Interestingly, TMEM45A expression was analysed
in one sample of normal human thymus, where epithelial cells
undergo keratinization as in epidermal keratinocytes thereby
forming Hassal bodies. Accordingly, TM protein 45A immunore-
activity was indeed restricted to Hassal bodies (Fig. 2e). Co-detec-
tions of TM protein 45A with KRT14, KRT10 or FLG in the
thymus revealed that TM protein 45A signal was detected in asso-







Figure 1. Upregulation of TMEM45A during confluence-induced differentiation of
keratinocyte autocrine monolayers and predominance of TMEM45A mRNA/protein
accumulation in the granular layer of human epidermis. (a) Relative quantification
of TMEM45A mRNA 2 days before confluence (C-2d), at confluence (C), 2 days
(C+2d) and 4 days after confluence (C+4d). Results were normalized to geometric
mean values of RPLP0 and TBP house-keeping genes. The ‘C-2d’ condition level
was arbitrarily fixed at 1. Error bars represent 95% confidence intervals (n = 3,
one-way repeated-measures ANOVA, *P < 0.05, **P < 0.01, ***P < 0.001). (b)
Immunoperoxidase labelling of transmembrane protein 45A 3 days before
confluence (C-3d), at confluence (C) and 2 days after confluence (C+2d). Hemalun
staining of nuclei (scale bars: 100 lm). (c) Co-immunofluorescence labelling of
transmembrane protein 45A with KRT10 or IVL 4 days after confluence. Nuclei
were stained with Hoechst (scale bars: 50 lm). (d, e) Immunoperoxidase labelling
of TM protein 45A in skin. Hemalun staining of nuclei (scale bars: 50 lm).
Epidermis and dermal cells show immunoreactivity (arrows). Asterisks indicate
cornified layer. Negative control was incubated without primary antibody (e). (f, g)
Immunofluorescence labelling of TM protein 45A in skin. TO-PRO-3 staining of
nuclei. Pictures show the same field in different Z-planes (scale bars: 50 lm). (h)
Relative mRNA levels of KRT14, KLK7, CDSN and TMEM45A genes in T1, T2, T3
and T4 fractions obtained by trypsin dissociation of epidermal keratinocytes. mRNA
levels were normalized to HPRT1 house-keeping gene. The level in T1 was fixed at
1. Results from one representative experiment (n = 2).
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was surrounded by KRT14 localized outside keratinized Hassal
bodies as described (23) (Fig. 2e).
TM protein 45A partially accumulates in the trans-Golgi/
trans-Golgi network of keratinocytes and does not reach the
lysosomal compartment
The subcellular localization of TM protein 45A was analysed using
confocal microscopy. In keratinocytes grown as monolayers, TM
protein 45A immunoreactivity was located in the cytoplasm, with
a mostly perinuclear distribution (Fig. 3a, b). Because TM protein
45A is a putative transmembrane protein, its location was com-
pared to specific markers of the endomembrane system. CALN,
GM130 and golgin-97 were investigated, respectively, as a molecu-
lar chaperone of the endoplasmic reticulum (24), as a cis-Golgi/
cis-Golgi network matrix protein and as a trans-Golgi/trans-Golgi
network protein (25) in cultured keratinocytes (Fig. 3a). No co-
localization of TM protein 45A with CALN was observed, whereas
frequent but partial co-localization with golgin-97 was found,
indicating the likely localization of TM protein 45A in trans-
Golgi/trans-Golgi network. Interestingly and in perfect accordance
with a localization of TM protein 45A in trans-Golgi compart-
ment, the TM protein 45A signal was often interlocked with
GM130 immunoreactivity, suggesting that TM protein 45A is
localized in an organelle intimately associated with the cis-Golgi/
cis-Golgi network compartment. The same results were obtained
at all cell densities (data not shown). To confirm a relationship
between TM protein 45A and the Golgi apparatus, brefeldin A
was used to interfere with the structural organization of this orga-
nelle (Fig. 3b). As expected, CALN localization was unaffected by
incubation with brefeldin A, whereas the localization of both
GM130 and golgin-97 was disrupted. In accordance with associa-
tion of TM protein 45A with the Golgi apparatus, the localization
of TM protein 45A was disrupted by brefeldin A.
To confirm this result in vivo, co-detections of TM protein 45A
with GM130 and golgin-97 were also performed on histological
sections of normal human skin (Fig. 4a). TM protein 45A signal
was mostly located in granular layer of the epidermis. There, TM
protein 45A was often localized side by side and alternating with
GM130. However, it was not associated with GM130 in more
superficial locations. This seems to correspond to its presence in
cornified keratinocytes. As observed in cultured cells, TM protein
45A also co-localized, although partially, with golgin-97 in granu-
lar keratinocytes.
Thus, association of TM protein 45A with the trans-Golgi/
trans-Golgi network was demonstrated, but as this was not its
only location, a potential association with the lysosomal compart-
ment was also investigated through co-detection with LAMP1 in
cultured keratinocytes (Figure S5a). Using a validated antibody
against LAMP1 (26), no co-localization was observed, indicating
that TM protein 45A does not reach the lysosomal compartment.
Ultrastructural analysis of epidermal TM protein 45A
Immunogold-labelling of TM protein 45A was used to further






Figure 2. TM protein 45A accumulates in thymic Hassal bodies, but is not
detected in non-keratinized stratified epithelium. Immunofluorescence labelling of
TM protein 45A in normal human non-keratinized mouth epithelium (a, b) and in
normal human skin (c, d). Negative controls were produced by incubation without
primary antibody (b and d). Nuclei were stained with Hoechst 33258 (scale bars:
100 lm). Keratinocytes and fibroblasts show immunoreactivity (arrows). (e)
Immunofluorescence labelling of TM protein 45A, KRT14, KRT10 and FLG in
thymus. Nuclei were stained with Hoechst 33258 (scale bars: 50 lm).
(a)
(b)
Figure 3. Association of TM protein 45A with the Golgi apparatus in normal
human epidermal keratinocytes. (a) Immunolabelling of TM protein 45A, CALN,
GM130 and golgin-97 (scale bars: 10 lm). (b) Immunolabelling of CALN, GM130,
golgin-97 and TM protein 45A of confluent cultures incubated without (control) or
with brefeldin A 10 lg/ml for 30 min. Nuclei were stained with TO-PRO-3 (scale
bars: 25 lm).
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In granular keratinocytes, a high number of gold particles were
detected in small intra-cellular membrane vesicles (Fig. 4b). Some
labelling was also observed associated with intermediate filaments
in the vicinity of keratohyalin granules (Fig. 4b), as well as close to
desmosomes (Figure S4a). Inside corneocytes, gold-labelling was
dispersed, sometimes associated with anchorage sites of intermedi-
ate filaments to corneodesmosomes (Figure S4b). Those localiza-
tions concur with the immunofluorescence labelling shown on
Fig. 1d–g.
TM protein 45A is not transported with corneodesmosin in
lamellar bodies
Several observations indicate that TM protein 45A could be
related to lamellar bodies with namely a punctated distribution in
granular layer, a predicted transmembrane localization of the pro-
tein, a possible involvement during keratinization, its detection in
trans-Golgi/trans-Golgi network and its ultrastructural detection
in particular vesicles. To test this hypothesis, co-detection of TM
protein 45A was performed in normal epidermis with CDSN, one
of cargoes of lamellar bodies, using a validated antibody (27). No
or very scarce co-localization could be observed in the granular
layer (Figure S5b), indicating that TM protein 45A is likely not
transported with CDSN in lamellar bodies. However, because car-
goes are known to be transported as distinct aggregates (28), this
result does not exclude potential relationship of TM protein 45A
with lamellar bodies.
Discussion
This study confirms that TMEM45A expression in human kerat-
inocytes, although present in subconfluent undifferentiated
keratinocytes, is upregulated during epidermal differentiation,
either induced by culture confluence or enhancement of Ca2+
concentration in medium, as previously published (13,14). It
also demonstrates strong connection between TMEM45A expres-
sion and keratinization, in both epidermis in vivo or during
reconstruction in culture, but also in Hassal bodies inside the
thymus. TMEM45A gene expression is increased in parallel with
differentiation in cultured keratinocytes and its protein product
accumulates during epidermal morphogenesis in vitro. Finally,
although present in basal and spinous layers, TM protein 45A
accumulation culminates in the granular layer in vivo. Alto-
gether, these data establish TMEM45A expression as a late mar-
ker of epidermal differentiation and suggest that it could be an
actor of keratinization. These results are consistent with pub-
lished literature identifying TMEM45A gene as a novel human
keratinization-associated gene (15), strongly expressed in late
stage of keratinization (7) and as a novel gene selectively and
highly expressed in normal human skin (14). This study allows
to compile dispersed, but important findings about the link
between TMEM45A expression and keratinization that still
requests further investigation.
TMEM45A mRNA was found upregulated in psoriasis and acti-
nic keratosis (14,16). In both epidermal pathologies, proliferation
and differentiation processes of keratinocytes are disrupted, leading
to hyperplasia, hyperkeratosis and parakeratosis (29–32). As these
pathologies are characterized respectively by the loss and thinning
of the granular layer, results showing upregulation of TMEM45A
expression in these conditions were unexpected (30,33). Moreover,
TMEM45A was found downregulated in cutaneous squamous cell
carcinoma in comparison with actinic keratosis (17), a frequent
precursor lesion of squamous cell carcinoma in humans (32). This
result could suggest that TMEM45A expression is not required for
progression and invasion of cancerous keratinocytes. In breast can-
cer cells, the gene was shown suppressing progression of ductal car-
cinoma into invasive breast cancer (18). However, in another study
on breast and liver cancer cells, TMEM45A expression was shown
essential for hypoxia-induced resistance against drug-induced apop-
tosis (13). Potential deregulations or implications of TMEM45A in
skin pathologies and cancers regarding its association with keratini-
zation need to be further investigated.
Other members of the heterogeneous TMEM family are still
poorly characterized, but new findings show potential importance
in epidermis functionality or in chemoresistance of cancer cells.
Tmem79 (Matt) gene is linked to Golgi apparatus and to lamellar
body secretion; altered cornified barrier formation and dermatitis
are observed in Tmem79ma/ma mutant mice (34). Transmembrane
protein 205 is associated with drug resistance of squamous carci-
noma, probably by altered membrane trafficking and secretion
(35).
For the first time, TM protein 45A precise subcellular localiza-
tion is reported in keratinocytes. It partially accumulates in trans-
Golgi/trans-Golgi network, both in vitro and in the granular layer
in vivo, in perfect accordance with its localization close to cis-
Golgi/cis-Golgi network. Moreover, its localization is disrupted by
brefeldin A, supporting strong relationship with Golgi apparatus.
However, other localizations may be suspected, whereas our data
exclude lysosomes as well as CDSN-containing lamellar bodies.
Nevertheless, transport with other cargoes cannot be excluded.
(a)
(b)
Figure 4. Transmembrane protein 45A localization in epidermis. (a)
Immunohistochemical staining of GM130, golgin-97 and TM protein 45A in human
epidermis. Nuclei were stained with TO-PRO-3. The asterisks indicate the cornified
layer. The right panel is a magnification of the merge (scale bars: 10 lm). (b)
Postembedding immuno-electron microscopy of normal human epidermis using
Lowicryl K4M resin and 5 nm immunogold-labelled secondary antibody. The
picture illustrates a granular keratinocyte with keratohyalin granule (KH). Arrows
indicate labelled membrane vesicles.
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Using electron microscopy, TM protein 45A immunoreactivity
was associated with membrane vesicles in granular keratinocytes.
The signal was also found at the level of insertion sites of interme-
diate filaments in the vicinity of keratohyalin granules and desmo-
somes in the granular layer, as well as in anchorage sites of
intermediate filaments to corneodesmosomes in the cornified
layer. This result suggests a possible association with cytoskeleton.
In conclusion, TMEM45A/transmembrane protein 45, linked to
Golgi apparatus, is associated with epidermal keratinization. This
strong relationship indicates the relevance of TMEM45A in this
process. Additional functional studies are currently performed to
get more insight into its roles.
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Figure  S1. Validation of anti-transmembrane protein 45A antibody by 
immunofluorescence labelling in human skin. Nuclei were stained with Hoechst 33258 
(scale bars: 50 µm).  
(a) Incubation with primary antibody anti-TM protein 45A was followed by incubation with 
secondary antibody.  
(b) Primary antibody anti-TM protein 45A was incubated with 30 fold excess immunogenic 
peptide before incubation with tissue. This was followed by incubation with secondary 
antibody.  




Figure S2. Upregulation of TMEM45A expression during Ca
2+
-induced differentiation 
in cultures of human keratinocytes cultured as monolayers. 
Subconfluent cultures at low cell density were incubated with high calcium concentration (1.5 
mM Ca
2+
) during 48 hours. Cultures incubated with the usual calcium concentration (0.06 
mM Ca
2+
) were used as reference. mRNA levels were normalized to geometric mean values 
of two house-keeping genes (RPLP0 and TBP). The mRNA level in the 0.06 mM Ca
2+
 
condition was used as reference and arbitrarily fixed at 1. Error bars represent 95% 





Figure S3. TMEM45A expression during epidermal morphogenesis at air-liquid 
interface on polycarbonate filter. The reconstructed human epidermis was analyzed one day 
after seeding the culture (1d), and then every second day until the eleventh day of 
reconstruction (11d). 
(a) mRNA levels were normalized to geometric mean values of TBP and RPLP0 house-
keeping genes. Level after one day of reconstruction (1d) was arbitrarily fixed at 1. Error bars 
represent 95% confidence intervals (n=4, one-way Repeated Measures ANOVA). No 
statistically significant variation was observed.  
(b) Immunofluorescent labelling of TM protein 45A. Reconstructed human epidermis stained 
with Hemalun Erythrosin (HE) or labelled for TM protein 45A detection, followed by DNA-




Figure S4. Transmembrane protein 45A localization in epidermis. Post-embedding 
immuno-electron microscopy of normal human epidermis using Lowicryl K4M resin and 5 
nm immunogold-labeled secondary antibody. (a) Desmosome in the granular layer. (b) 







Figure S5. Co-detections of TM protein 45A with LAMP1 in vitro and with CDSN in the 
granular layer of epidermis. 
 (a) Immunolabelling of TM protein 45A and LAMP1 in normal human epidermal 
keratinocytes cultured as autocrine monolayers. Nuclei were stained with TO-PRO-3 (scale 
bars: 25 µm).  
(b) Immunolabelling of TM protein 45A and CDSN in human normal epidermis. Nuclei were 
















Antibodies, immunogenic peptide and chemicals 
Rabbit anti-TM protein 45A antibody n° HPA024082 (dilution 1:50 or 1:100), mouse anti-
IVL antibody n° I9018 (dilution 1:200) and brefeldin A n° B7651 were purchased from 
Sigma-Aldrich (Saint-Louis, MO, US). Mouse anti-GM130 antibody n° 610822 (dilution 
1:100 for cells and 1:300 for tissues) was obtained from BD (Franklin Lakes, NJ, US). Mouse 
anti-CALN antibody n° MA3-027 (dilution 1:500) came from Thermo Fisher Scientific 
(Waltham, MA, USA). Mouse anti-golgin-97 antibody n° A-21270 (dilution 1:100), Hoechst 
33258, TO-PRO-3, Alexa fluor 488-conjugated goat anti-rabbit antibody (dilution 1:200) and 
Alexa fluor 546-conjugated goat anti-mouse antibody (dilution 1:200 or 1:500) were 
purchased from Life technologies (Carlsbad, CA, US). Mouse anti-KRT10 antibody n° 
M7002 (dilution 1:100) and DAB system n° K3468 were obtained from Dako (Glostrup, 
Denmark). Mouse anti-LAMP1 antibody (H4A3) (dilution 1:50) was from DSHB (Iowa City, 
Iowa, US). Mouse anti-FLG antibody n° MS-449-P1 (dilution 1:75) was obtained from 
Neomarkers (Fremont, CA, US). Mouse anti-KRT14 antibody n° LL002 (dilution 1:50) was 
purchased from Santa Cruz (Dallas, Texas, USA). Vectastain ABC Kit peroxidase was 
purchased from Vector laboratories (Burlingame, CA, US). TMEM45A immunogenic peptide 
was given by ATLAS ANTIBODIES (Stockholm, Sweden). Mouse anti-CDSN G36-19 
antibody (dilution 1:3,000) was given by Guy Serre (UMR5165/U1056 CNRS-INSERM-
University of Toulouse, UDEAR, Toulouse, France).  
 
Primers for real-time PCR (keratinocyte monolayers and reconstructed human 
epidermis) 
Gene Forward primer (5’-3’) Reverse primer (3’-5’) 





KRT14 CGATGGCAAGGTGGTGTC GGGTGAAGCAGGGTCCAG 
RPLP0 ATCAACGGGTACAAACGAGTC CAGATGGATCAGCCAAGAAGG 
TPB TCAAACCCAGAATTGTTCTCCTTAT CCTGAATCCCTTTAGAATAGGGT
AGA 
TMEM45A  TTATGCAGTAACCATTGTCATCGTT TGATTCTTGTTCTCGTTCAGCATT 
 
Primers for real-time PCR (epidermal dissociation) 
Gene Forward primer (5’-3’) Reverse primer (3’-5’) 
KRT14 GAGGAGACCAAAGGTCGCTA CTGGATGACTGCGATCCAGA 
KLK7 CTCATGCTCGTGAAGCTCAA GGTCAGAGGGAAAGGTCACA 
CDSN CGTATCACCTCCCCTAACGA AGGAGTAGCTGACCTGGGAA 
HPRT1 ACCCCACGAAGTGTTGGATA AAGCAGATGGCCACAGAACT 




Immunofluorescence labelling on tissues and cells 
Paraffin-embedded sections were deparaffinized and rehydrated. For TM protein 45A 
detection, heat-induced antigen retrieval was performed by incubating sections in 10 mM 
citrate buffer at pH6 and 95°C for 20 minutes. Cryosections and coverslips with seeded cells 
were fixed for 15 min in PBS- PFA 4% buffered at pH 7.2. After rinsing in PBS-CaCl2 
(0.01%), cryosections, paraffin sections and coverslips were incubated in 0.1 M glycine. 
Paraffin sections were blocked for 30 minutes in PBS-BSA (0.2%)-CaCl2 (0.01%). 
Cryosections and coverslips were blocked and permeabilized in PBS-BSA (0.2%)-Triton X-
100 (0.02%)-CaCl2 (0.01%) for 30 minutes. Incubation (from 45 minutes to 2 hours or 
overnight) with primary antibody diluted in PBS-BSA-Triton X-100-CaCl2 (cryosections and 
coverslips) or PBS-BSA-CaCl2 (paraffin sections) was performed. Negative controls were 
obtained by incubating sections and coverslips in buffer without primary antibody. Sections 
and coverslips were incubated for one hour with secondary Alexa fluor. Nuclei were stained 
with Hoechst 33258 or TO-PRO-3. Labelled tissues and cells were analyzed under Olympus 
AX70 microscope (Tokyo, Japan) or Leica TCS SP5II confocal microscope (Solms, 
Germany).  
 
Peroxidase labelling on tissues and cells  
Cryosections and coverslips with seeded cells were fixed for 15 minutes in PBS- PFA 4% 
buffered at pH 7.2. After rinsing in PBS-CaCl2 (0.01%), they were incubated in 0.1 M 
glycine. Cryosections and coverslips were incubated in 3% H2O2 for 10 minutes. They were 
blocked and permeabilized in PBS-BSA (0.2%)-Triton X-100 (0.02%)-CaCl2 (0.01%) for 30 
minutes. Cryosections and coverslips were incubated for 1-2 hours or overnight with primary 
antibody diluted in PBS-BSA-Triton X-100-CaCl2. Negative controls were obtained by 
incubating sections and coverslips in PBS-BSA-Triton X-100-CaCl2 without primary 
antibody. Cryosections and coverslips were incubated for 45 min with biotinylated secondary 
antibody diluted 1:100 in PBS-BSA-Triton X-100. After washes, sections and coverslips were 
incubated for 30 minutes with streptavidin-peroxidase solution. Detection of HRP was 
performed using the high-sensitivity DAB system. Reaction was stopped in distilled water. 
Counterstaining with hemalun was perfomed. For observation, an Olympus AX70 microscope 
(Tokyo, Japan) was used. 
 
Immunoelectron microscopy 
Normal human skin fixed in 3% paraformaldehyde/PBS and low-temperature embedded in 
Lowicryl K4M (Leica, Germany) was used for on-section immunogold labeling [1]. Ultrafine 
sections, harvested on nickel grids, were first pretreated for 10 min. at 60°C with 10% sodium 
metaperiodate for surface etching and optimum antigen retrieval. After washes in water and 
incubation with a blocking buffer containing 5% normal goat serum, the sections were 
exposed to the primary antibody diluted 1:50, in PBS supplemented with 0.1% goat serum 
and 0.01% gelatin, at 4°C overnight. After washes, the primary antibody binding sites were 
revealed using goat anti-rabbit 5 nm immunogold-labeled secondary antibody (diluted 1:10, 
1h at r.t.; British Biocell International, Cardiff, UK). After final washes, the sections were 




1. Haftek, M., et al., Expression of corneodesmosin in the granular layer and stratum 
corneum of normal and diseased epidermis. Br J Dermatol, 1997. 137(6): p. 864-73. 
 
 
